| Authors: |
Millan B; Urologic Oncology Branch, National Cancer Institute, Bethesda, MD., Ghosh S; Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB., Basappa NS; Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB., Wood L; Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, NS., Bhindi B; Southern Alberta Institute of Urology, Calgary, AB., Pouliot F; CHU de Quebec, Université Laval, Quebec City, QC., Breau RH; Ottawa Hospital, Ottawa, ON., Finelli A; University of Toronto, Toronto, ON., Bansal RK; St Joseph Healthcare Hamilton, Hamilton, ON., Graham J; CancerCare Manitoba, University of Manitoba, Winnipeg, MB., Bjarnason GA; Sunnybrook Odette Cancer Centre, Toronto, ON., Bosse D; University of Ottawa, Ottawa, ON., Castonguay V; Hotel Dieu de Quebec, Quebec, QC., Winquist E; Verspeeten Family Cancer Centre at London Health Sciences Centre and Western University, London, ON., Heng DYC; Arthur J.E. Child Comprehensive Cancer Centre, University of Calgary, Calgary, AB., Kollmannsberger CK; British Columbia Cancer Agency, Vancouver Centre, Vancouver, BC., Lalani AA; Juravinski Cancer Centre, McMaster University, Hamilton, ON. Electronic address: lalania@hhsc.ca. |
